DIANE SCHMIDT: Open Payments
NPI 1689679763 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,762 in 77 payments from 25 companies in 2025. Trend: 2023 $1,681 · 2024 $2,228 · 2025 $1,762
Food & beverage: $1,662Education: $100
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 18 | $370 |
| ABBVIE INC. | 8 | $178 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $177 |
| Astellas Pharma US Inc | 3 | $162 |
| PFIZER INC. | 5 | $123 |
| Janssen Biotech, Inc. | 6 | $113 |
| UROGEN PHARMA, INC. | 3 | $69 |
| PROGENICS PHARMACEUTICALS, INC. | 3 | $67 |
| Merck Sharp & Dohme LLC | 2 | $49 |
| Antares Pharma, Inc. | 2 | $46 |
Products named: GEMTESA, XTANDI, Nubeqa, ORGOVYX, BOTOX, ERLEADA, PYLARIFY, JELMYTO.
Industry payments across MD — which companies pay providers there.
